Ensign Peak Advisors, Inc 10x Genomics, Inc. Transaction History

Ensign Peak Advisors, Inc

  • $54.2 Billion
  • Q2 2024

A detailed history of Ensign Peak Advisors, Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 29,140 shares of TXG stock, worth $455,749. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,140
Previous 51,593 43.52%
Holding current value
$455,749
Previous $1.94 Million 70.76%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$19.45 - $37.37 $436,710 - $839,068
-22,453 Reduced 43.52%
29,140 $566,000
Q1 2024

May 14, 2024
BUY
$36.08 - $54.3 $530,953 - $799,078
14,716 Added 39.91%
51,593 $1.94 Million
Q4 2023

Feb 14, 2024
BUY
$34.32 - $57.55 $5,079 - $8,517
148 Added 0.4%
36,877 $2.06 Million
Q3 2023

Nov 13, 2023
SELL
$40.86 - $62.98 $736,624 - $1.14 Million
-18,028 Reduced 32.92%
36,729 $1.52 Million
Q2 2023

Aug 14, 2023
BUY
$50.96 - $58.72 $1.08 Million - $1.24 Million
21,129 Added 62.83%
54,757 $3.06 Million
Q1 2023

May 15, 2023
SELL
$35.33 - $55.79 $1.5 Million - $2.36 Million
-42,389 Reduced 55.76%
33,628 $1.88 Million
Q4 2022

Feb 13, 2023
BUY
$24.4 - $41.3 $1.26 Million - $2.14 Million
51,740 Added 213.12%
76,017 $2.77 Million
Q3 2022

Nov 14, 2022
SELL
$28.48 - $52.59 $560,400 - $1.03 Million
-19,677 Reduced 44.77%
24,277 $692,000
Q2 2022

Aug 12, 2022
BUY
$36.95 - $82.41 $241,468 - $538,549
6,535 Added 17.46%
43,954 $1.99 Million
Q1 2022

May 16, 2022
SELL
$55.7 - $145.79 $1.04 Million - $2.72 Million
-18,681 Reduced 33.3%
37,419 $2.85 Million
Q4 2021

Feb 11, 2022
BUY
$135.05 - $182.59 $2.54 Million - $3.43 Million
18,800 Added 50.4%
56,100 $8.36 Million
Q3 2021

Nov 12, 2021
SELL
$145.58 - $192.14 $3.36 Million - $4.43 Million
-23,080 Reduced 38.22%
37,300 $5.43 Million
Q2 2021

Aug 13, 2021
BUY
$134.22 - $202.37 $908,132 - $1.37 Million
6,766 Added 12.62%
60,380 $11.8 Million
Q1 2021

May 12, 2021
SELL
$140.25 - $196.86 $2.29 Million - $3.22 Million
-16,345 Reduced 23.36%
53,614 $9.71 Million
Q4 2020

Feb 12, 2021
SELL
$126.47 - $163.7 $2.65 Million - $3.43 Million
-20,961 Reduced 23.05%
69,959 $9.91 Million
Q3 2020

Nov 12, 2020
BUY
$87.44 - $125.0 $3.44 Million - $4.92 Million
39,334 Added 76.25%
90,920 $11.3 Million
Q2 2020

Aug 12, 2020
SELL
$58.39 - $89.31 $518,853 - $793,608
-8,886 Reduced 14.69%
51,586 $4.61 Million
Q1 2020

May 11, 2020
BUY
$51.57 - $106.62 $930,683 - $1.92 Million
18,047 Added 42.54%
60,472 $3.77 Million
Q4 2019

Feb 14, 2020
BUY
$46.07 - $79.54 $1.95 Million - $3.37 Million
42,425 New
42,425 $3.24 Million

Others Institutions Holding TXG

# of Institutions
289
Shares Held
95.3M
Call Options Held
162K
Put Options Held
107K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.49B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email